Fresenius | FRE - Sales Revenues


Fresenius reported EUR5.95B in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Akzo Nobel EUR 2.59B 200M Jun/2026
Alcon AG USD 2.69B 10M Mar/2026
AstraZeneca USD 15.38B 90M Jun/2026
BASF EUR 17.21B 1.19B Jun/2026
Bayer EUR 10.87B 2.54B Jun/2026
Beiersdorf EUR 2.45B 30M Jun/2026
DaVita Healthcare Partners USD 3.55B 130M Jun/2026
Demant DKK 6.25B 800M Dec/2025
E.ON EUR 21.82B 630M Mar/2026
Essilor EUR 14.82B 351M Jun/2026
Fresenius EUR 5.95B 210M Jun/2026
Fresenius Medical Care EUR 4.86B 250M Jun/2026
Getinge SEK 8.38B 1000K Jun/2026
Givaudan CHF 3.61B 256M Dec/2025
GlaxoSmithKline GBP 8.41B 781M Jun/2026
GN Store Nord DKK 3.85B 830M Mar/2026
GRIFOLS EUR 1.87B 170M Jun/2026
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Lonza CHF 3.58B 63M Jun/2025
Merck EUR 5.13B 120M Mar/2026
Novartis USD 14.41B 1.3B Jun/2026
Philips EUR 4.36B 450M Jun/2026
Roche Holding CHF 30.36B 14.71B Jun/2026
RWE EUR 4.34B 220M Mar/2026
Sanofi EUR 11.95B 710M Jun/2026
Smith & Nephew USD 1.6B 1.58B Jun/2026